NL171589B - METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION EFFECTIVE AGAINST VIRUS INFECTIONS, AND METHOD FOR PREPARING A 9- (BETA-D-ARABINOFURANOSYL) PURINE - Google Patents

METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION EFFECTIVE AGAINST VIRUS INFECTIONS, AND METHOD FOR PREPARING A 9- (BETA-D-ARABINOFURANOSYL) PURINE

Info

Publication number
NL171589B
NL171589B NLAANVRAGE7016766,A NL7016766A NL171589B NL 171589 B NL171589 B NL 171589B NL 7016766 A NL7016766 A NL 7016766A NL 171589 B NL171589 B NL 171589B
Authority
NL
Netherlands
Prior art keywords
preparing
arabinofuranosyl
purine
beta
pharmaceutical preparation
Prior art date
Application number
NLAANVRAGE7016766,A
Other languages
Dutch (nl)
Other versions
NL7016766A (en
NL171589C (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL7016766A publication Critical patent/NL7016766A/xx
Publication of NL171589B publication Critical patent/NL171589B/en
Application granted granted Critical
Publication of NL171589C publication Critical patent/NL171589C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NLAANVRAGE7016766,A 1969-11-17 1970-11-16 METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION EFFECTIVE AGAINST VIRUS INFECTIONS, AND METHOD FOR PREPARING A 9- (BETA-D-ARABINOFURANOSYL) PURINE NL171589C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (3)

Publication Number Publication Date
NL7016766A NL7016766A (en) 1971-05-19
NL171589B true NL171589B (en) 1982-11-16
NL171589C NL171589C (en) 1983-04-18

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7016766,A NL171589C (en) 1969-11-17 1970-11-16 METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION EFFECTIVE AGAINST VIRUS INFECTIONS, AND METHOD FOR PREPARING A 9- (BETA-D-ARABINOFURANOSYL) PURINE

Country Status (26)

Country Link
US (1) US3666856A (en)
JP (1) JPS5429520B1 (en)
AT (1) AT309696B (en)
BE (1) BE759011A (en)
BR (1) BR6915136D0 (en)
CA (1) CA967564A (en)
CH (2) CH555833A (en)
CS (1) CS181701B2 (en)
DE (1) DE2056327C2 (en)
DK (1) DK128117B (en)
ES (2) ES385590A1 (en)
FI (1) FI54315C (en)
FR (1) FR2073364B1 (en)
GB (2) GB1338905A (en)
HU (1) HU163812B (en)
IE (1) IE34737B1 (en)
IL (1) IL35658A (en)
LU (1) LU62071A1 (en)
MC (1) MC869A1 (en)
NL (1) NL171589C (en)
NO (1) NO128156B (en)
PL (1) PL81167B1 (en)
SE (1) SE385374B (en)
YU (2) YU35033B (en)
ZA (1) ZA707722B (en)
ZM (1) ZM12970A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (en) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin USE OF ADENOSINE IN THE TREATMENT OF HERPES
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
ATE128141T1 (en) * 1988-03-16 1995-10-15 Scripps Research Inst SUBSTITUTED ADENINE DERIVATIVES USABLE AS THERAPEUTIC AGENTS.
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001273212A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (en) * 2015-06-25 2018-05-18 新乡学院 A kind of preparation method of 2- amino arabinosy ladenosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (en) * 1996-09-20 1998-04-14 Sony Corp Production control method

Also Published As

Publication number Publication date
GB1338906A (en) 1973-11-28
ZM12970A1 (en) 1972-07-21
NL7016766A (en) 1971-05-19
BR6915136D0 (en) 1973-04-19
NO128156B (en) 1973-10-08
CA967564A (en) 1975-05-13
LU62071A1 (en) 1971-08-12
IE34737L (en) 1971-05-17
IE34737B1 (en) 1975-08-06
YU201978A (en) 1979-12-31
ES385590A1 (en) 1973-10-01
CS181701B2 (en) 1978-03-31
YU280670A (en) 1979-12-31
DK128117B (en) 1974-03-04
YU35033B (en) 1980-06-30
CH555833A (en) 1974-11-15
US3666856A (en) 1972-05-30
DE2056327C2 (en) 1984-10-11
IL35658A (en) 1974-10-22
DE2056327A1 (en) 1971-06-03
PL81167B1 (en) 1975-08-30
NL171589C (en) 1983-04-18
FI54315B (en) 1978-07-31
YU35034B (en) 1980-06-30
ES413787A1 (en) 1976-01-16
GB1338905A (en) 1973-11-28
FR2073364B1 (en) 1974-03-22
HU163812B (en) 1973-10-27
MC869A1 (en) 1971-09-28
SE385374B (en) 1976-06-28
BE759011A (en) 1971-05-17
CH555344A (en) 1974-10-31
FI54315C (en) 1978-11-10
ZA707722B (en) 1972-06-28
IL35658A0 (en) 1971-01-28
JPS5429520B1 (en) 1979-09-25
AT309696B (en) 1973-08-27
FR2073364A1 (en) 1971-10-01

Similar Documents

Publication Publication Date Title
NL171589C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION EFFECTIVE AGAINST VIRUS INFECTIONS, AND METHOD FOR PREPARING A 9- (BETA-D-ARABINOFURANOSYL) PURINE
NL174943C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING AN 8-AZAPURIN-6 SUB-DERIVATIVE.
NL170143C (en) PROCESS FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-IGNITION ACTIVITY, AND METHOD FOR PREPARING POLYARYLIMIDAZOLES SUITABLE FOR IT.
NL163501C (en) METHOD FOR PREPARING FLUORENE DERIVATIVES, METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTI-VIRUS ACTION, CONTAINING THE FLUORENE DERIVATIVES PREPARED PREPARED THEREFORE USING THAT METHOD
NL171155C (en) METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH BRONCHI REMOVAL ACTION, AND METHOD FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS FOR USE THEREIN
NL170919B (en) PROCESS FOR PREPARING A DRIED VITAMIN PREPARATION.
NL168238C (en) METHOD FOR PREPARING AN ADHESIVE AND FORMED PRODUCTS MADE THEREFOR
NL168210C (en) METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING CYCLIC CARBONIC ACID DERIVATIVES.
NL169031B (en) PROCESS FOR PREPARING A VACCINE.
NL170284C (en) PROCESS FOR PREPARING 1.2.3.5.6.2.13.13A-OCTAHYDRO 12 OXOINDOLO 3.2.1-D.EŸPYRIDO 3.2.1-I.JŸNAFTYRIDINES AND PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL169615B (en) PROCESS FOR PREPARING AN ANTIBIOTIC AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-BACTERIAL AND ANTI-TUMOR ACTIVITY.
NL169585C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AGAINST LIVER BONE INFECTIONS, DOSED PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING THE ACTIVE SUBSTANCES
NL172657C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING USEFUL PYRAZOLOOL3.4-BŸ-PYRIDINE DERIVATIVES
NL168705C (en) METHOD FOR PREPARING AN ANTHELMINTIC PREPARATION
NL173167C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS, BASED ON N-ACYLTRYPTOPHANE DERIVATIVES, AND METHOD FOR PREPARING N-ACYLTRYPTOPHANE DERIVATIVES.
NL149812B (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING CRYSTALLINE CYTIDINE-5'-DIPHOSPHATE-CHOLINE-MONOHYDRATE.
NL161746B (en) PROCESS FOR THE PREPARATION OF CYSTEINE DERIVATIVES WITH ANTISEBORRHOEA ACTION, PROCESS FOR THE PREPARATION OF A COSMETIC AND / OR PHARMACEUTICAL PREPARATION, AND OBJECTS THEREOF.
NL166018C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS.
NL170595C (en) METHOD FOR PREPARING A VACCINE AGAINST NEWCASTLE DISEASE
NL165655C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND PROCESS FOR PREPARING SUITABLE PEPTIDES
NL168521C (en) PROCESS FOR PREPARING STEROID DERIVATIVES, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND FORMED PREPARATION
NL144923B (en) PROCESS FOR THE PREPARATION OF A NALFA-SUBSTITUTED 2-0-METHYLOXYTOCIN DERIVATIVE, PROCESS FOR PREPARING PHARMACEUTICAL AND FORMED PREPARATIONS.
NL162898C (en) A PROCESS FOR PREPARING AMIDINE DERIVATIVES WITH AN EFFICACY AGAINST SEROTONIN, AND A METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH AN EFFICACY AGAINST SEROTONIN.
NL7504890A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND PROCESS FOR THE PREPARATION OF NEW AZAMORFINAND DERIVATIVES.
NL156695B (en) PROCESS FOR PREPARING 2-IMINO 5-PHENYL-BENZODIAZEPINE DERIVATIVES, AND FORMED PHARMACEUTICAL PREPARATIONS.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee